STEGLATRO 15 mg/1
ertugliflozin · TABLET, FILM COATED · Merck Sharp & Dohme LLC
No Recall History
Plain English
STEGLATRO is a tablet, film coated containing ertugliflozin at 15 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- STEGLATRO
- Generic Name
- ertugliflozin
- NDC Code (Product)
0006-5364- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 15 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209803
- Marketing Start
- 12/19/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is STEGLATRO used for?
STEGLATRO contains ertugliflozin. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is STEGLATRO a controlled substance?
STEGLATRO is not classified as a controlled substance by the DEA.
What is the generic name for STEGLATRO?
The generic name for STEGLATRO is ertugliflozin. There are 6 other brand versions of ertugliflozin.
What is the NDC code for STEGLATRO 15 mg/1?
The NDC (National Drug Code) for STEGLATRO 15 mg/1 is 0006-5364, listed by Merck Sharp & Dohme LLC.